Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ko

Showing results (991-1000 of 1,232) with videos related to

Pageof 124
Sort By:
Family & Community Health|September 21, 2001
Cancer symptom control: feasibility of a tailored, interactive computerized program for patientsD J Wilkie, H Y Huang, D L Berry, et al.
Health Affairs (Project Hope)|October 4, 2021
Preventing Pregnancy-Related Mental Health Deaths: Insights From 14 US Maternal Mortality Review Committees, 2008-17Susanna L Trost, Jennifer L Beauregard, Ashley N Smoots, et al.
MMWR. Morbidity and Mortality Weekly Report|April 28, 2022
Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization - United States, 2017-2019Nicole D Ford, Shanna Cox, Jean Y Ko, et al.
Journal of Molecular and Cellular Cardiology|April 11, 2022
Synergistic FRET assays for drug discovery targeting RyR2 channelsRobynT Rebbeck, Kenneth S Ginsburg, Christopher Y Ko, et al.
Annals of Surgery|July 20, 2016
Evaluation of the ProPublica Surgeon Scorecard "Adjusted Complication Rate" Measure SpecificationsKristen A Ban, Mark E Cohen, Clifford Y Ko, et al.
Journal of Medicinal Chemistry|August 14, 1998
2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain modelsC Walpole, S Y Ko, M Brown, et al.
Worldviews on Evidence-Based Nursing|January 10, 2025
Effect of a Nurse-Led Support Program Using Mobile Application Versus Nurse Phone Advice on Patients at Risk of Coronary Artery Disease: A Randomized Controlled TrialEliza M L Wong, Doris Y P Leung, Simon C Lam, et al.
Journal of the American Heart Association|November 23, 2022
Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection FractionBence Hegyi, Juliana Mira Hernandez, Christopher Y Ko, et al.
Anesthesia and Analgesia|August 17, 2018
Evidence Review Conducted for the Agency for Healthcare Research and Quality Safety Program for Improving Surgical Care and Recovery: Focus on Anesthesiology for Bariatric SurgeryMichael C Grant, Melinda M Gibbons, Clifford Y Ko, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 22, 2015
Accuracy of Xpert(®) MTB/RIF assay compared with AdvanSure™ TB/NTM real-time PCR using bronchoscopy specimensY Ko, H-K Lee, Y S Lee, et al.
Pageof 124

Showing results (991-1000 of 1,232) with videos related to

Sort By:
Pageof 124
Family & Community Health|September 21, 2001
Cancer symptom control: feasibility of a tailored, interactive computerized program for patientsD J Wilkie, H Y Huang, D L Berry, et al.
Health Affairs (Project Hope)|October 4, 2021
Preventing Pregnancy-Related Mental Health Deaths: Insights From 14 US Maternal Mortality Review Committees, 2008-17Susanna L Trost, Jennifer L Beauregard, Ashley N Smoots, et al.
MMWR. Morbidity and Mortality Weekly Report|April 28, 2022
Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization - United States, 2017-2019Nicole D Ford, Shanna Cox, Jean Y Ko, et al.
Journal of Molecular and Cellular Cardiology|April 11, 2022
Synergistic FRET assays for drug discovery targeting RyR2 channelsRobynT Rebbeck, Kenneth S Ginsburg, Christopher Y Ko, et al.
Annals of Surgery|July 20, 2016
Evaluation of the ProPublica Surgeon Scorecard "Adjusted Complication Rate" Measure SpecificationsKristen A Ban, Mark E Cohen, Clifford Y Ko, et al.
Journal of Medicinal Chemistry|August 14, 1998
2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain modelsC Walpole, S Y Ko, M Brown, et al.
Worldviews on Evidence-Based Nursing|January 10, 2025
Effect of a Nurse-Led Support Program Using Mobile Application Versus Nurse Phone Advice on Patients at Risk of Coronary Artery Disease: A Randomized Controlled TrialEliza M L Wong, Doris Y P Leung, Simon C Lam, et al.
Journal of the American Heart Association|November 23, 2022
Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection FractionBence Hegyi, Juliana Mira Hernandez, Christopher Y Ko, et al.
Anesthesia and Analgesia|August 17, 2018
Evidence Review Conducted for the Agency for Healthcare Research and Quality Safety Program for Improving Surgical Care and Recovery: Focus on Anesthesiology for Bariatric SurgeryMichael C Grant, Melinda M Gibbons, Clifford Y Ko, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 22, 2015
Accuracy of Xpert(®) MTB/RIF assay compared with AdvanSure™ TB/NTM real-time PCR using bronchoscopy specimensY Ko, H-K Lee, Y S Lee, et al.
Pageof 124